Repligen Corp (RGEN) Reports Q1 EPS of $0.07; Guides FY13
Repligen Corp (NASDAQ: RGEN) reported Q1 EPS of $0.07, versus $0.04 reported last year ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
